APA (7th ed.) Citation

JS, C., BL, D., LA, G., BJ, B., & D, B. (2025). The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve. Molecular therapy : the journal of the American Society of Gene Therapy, 33(10), 4694. https://doi.org/10.1016/j.ymthe.2025.08.029

Chicago Style (17th ed.) Citation

JS, Chamberlain, Davidson BL, George LA, Byrne BJ, and Barrett D. "The Future of Gene Therapy: Safer Vectors, Sharper Focus: High-profile Failures Demand Deep Root Cause Analysis - but the Transformative Potential of AAV Remains Within Reach If the Field Is Willing to Learn and Evolve." Molecular Therapy : The Journal of the American Society of Gene Therapy 33, no. 10 (2025): 4694. https://doi.org/10.1016/j.ymthe.2025.08.029.

MLA (9th ed.) Citation

JS, Chamberlain, et al. "The Future of Gene Therapy: Safer Vectors, Sharper Focus: High-profile Failures Demand Deep Root Cause Analysis - but the Transformative Potential of AAV Remains Within Reach If the Field Is Willing to Learn and Evolve." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 33, no. 10, 2025, p. 4694, https://doi.org/10.1016/j.ymthe.2025.08.029.